A complete guide to understanding cholesterol numbers and managing cardiovascular risk — with expert top 5 picks for at-home cholesterol and lipid panel tests ranked by accuracy and completeness.
High cholesterol is a “silent” condition where excess LDL (bad cholesterol) builds up in artery walls, forming plaques that restrict blood flow and dramatically increase the risk of heart attack and stroke.
Cholesterol is a waxy, fat-like substance found in every cell of your body. While essential for producing hormones, vitamin D, and digestive bile, too much cholesterol — particularly LDL (low-density lipoprotein) — builds up in artery walls, forming plaques that restrict blood flow and dramatically increase the risk of heart attack and stroke.
High cholesterol affects 86 million Americans adults — nearly 1 in 3 — and the vast majority have no symptoms. The only way to know your cholesterol levels is through a blood test. At-home testing now enables regular monitoring between clinical visits, allowing earlier detection of rising levels and better tracking of treatment response.
The LDL goal: For most healthy adults, LDL below 100 mg/dL is optimal. For people with cardiovascular disease or diabetes, LDL below 70 mg/dL is the target. For those at very high risk (multiple prior heart attacks), below 55 mg/dL may be recommended.
| Marker | Optimal | Borderline | High Risk | Why It Matters |
|---|---|---|---|---|
| Total Cholesterol | <200 mg/dL | 200–239 | ≥240 mg/dL | Screening marker — context matters |
| LDL Cholesterol ⭐ | <100 mg/dL | 100–159 | ≥160 mg/dL | Primary driver of artery plaque — most important number |
| HDL Cholesterol ⭐ | ≥60 mg/dL | 40–59 | <40 mg/dL | "Good" cholesterol — higher is better; protective |
| Triglycerides | <150 mg/dL | 150–199 | ≥200 mg/dL | Reflects dietary fat + sugar; elevated = metabolic risk |
| Total/HDL Ratio | <3.5 | 3.5–5.0 | >5.0 | Best single predictor of cardiovascular risk |
High cholesterol has no symptoms — it's called a "silent" risk factor because arteries can narrow significantly before any warning signs appear. The first symptom of high cholesterol is often a heart attack or stroke.
Risk increases with age — men over 45, women over 55 should test regularly
Familial hypercholesterolemia affects 1 in 250 people; genetic high cholesterol from birth
High saturated fat, trans fat, and dietary cholesterol raise LDL
Regular exercise raises HDL and lowers LDL and triglycerides
Damages blood vessel walls and lowers HDL (good cholesterol)
Insulin resistance alters lipid metabolism — small, dense LDL particles are more atherogenic
Testing frequency guidelines: Adults 20–39 with no risk factors: every 5 years. Adults 40–75: every 1–2 years. Anyone on cholesterol-lowering medication: every 3–6 months to monitor treatment response. Anyone with new cardiovascular risk factors: immediate testing.
Reduce saturated fat (red meat, dairy, coconut oil) to below 7% of daily calories. Replace with unsaturated fats (olive oil, nuts, avocado). Each 1% reduction in saturated fat lowers LDL by ~2 mg/dL.
10–25g of soluble fiber daily (oats, beans, psyllium husk, flaxseed) reduces LDL by 5–10%. Metamucil (psyllium) is one of the most evidence-based dietary interventions for LDL reduction.
Fatty fish (salmon, mackerel, sardines) 2–3× per week or fish oil supplementation (2–4g EPA+DHA) reduces triglycerides by 20–30% and modestly improves HDL.
150 minutes of moderate aerobic exercise weekly raises HDL by 3–6 mg/dL and lowers LDL and triglycerides. Resistance training provides additional benefit.
2g of plant sterols/stanols daily (found in fortified foods or supplements) reduces LDL by 5–15% by competing with cholesterol absorption in the gut.
Quitting smoking raises HDL by 5–10 mg/dL within 1 year and reverses smoking-related arterial damage over time.
| Medication | Class | LDL Reduction | Best For |
|---|---|---|---|
| Atorvastatin, Rosuvastatin | High-intensity statin | 45–55% LDL reduction | First-line for high CV risk; most prescribed class |
| Simvastatin, Pravastatin | Moderate-intensity statin | 30–40% LDL reduction | Lower-risk patients or statin-intolerant at high doses |
| Ezetimibe (Zetia) | Cholesterol absorption inhibitor | 15–20% additional LDL reduction | Add-on to statin; well-tolerated |
| Evolocumab, Alirocumab | PCSK9 inhibitors (injection) | 50–60% additional LDL reduction | Very high risk; prior heart attack; familial hypercholesterolemia |
| Bempedoic acid (Nexletol) | ATP-citrate lyase inhibitor | 15–20% LDL reduction | Statin-intolerant patients; oral alternative |
| Icosapentaenoic acid (Vascepa) | Omega-3 prescription | ~25% TG reduction + CV benefit | High triglycerides + high CV risk |
Home monitoring value: For patients on statins or other cholesterol medications, at-home testing between clinical visits enables faster detection of treatment response issues, dietary impact, and medication non-compliance — reducing the delay between a problem and a medication adjustment.
#1 Pick: Everlywell Cholesterol & Lipids Test · Score: 9.5/10 · 5 products tested
Fasting for 9–12 hours before testing is required for an accurate LDL measurement. Without fasting, recent dietary fat temporarily raises triglycerides, which in turn causes the Friedewald equation to underestimate LDL. Total cholesterol and HDL are not significantly affected by fasting. For at-home tests, always test first thing in the morning after an overnight fast for the most accurate results. For direct LDL measurement (non-calculated), fasting is less critical — ask your testing service which method they use.
CLIA-certified lab-send tests (Everlywell, LetsGetChecked) achieve ±10–12% accuracy vs clinical venous blood draws. Instant handheld devices (CardioChek) achieve ±15%. Both are adequate for trend monitoring — detecting whether your cholesterol is rising or falling — but not for precise clinical decision-making. Treatment adjustments (changing statin dose, adding medication) should always be based on a clinical venous blood draw, not home test results alone.
LDL cholesterol (low-density lipoprotein) is the primary driver of atherosclerosis (artery plaque buildup) and the main target of treatment. However, the total/HDL ratio is actually the best single predictor of cardiovascular risk — it accounts for both the harmful LDL and the protective HDL in one number. A total/HDL ratio below 3.5 is optimal. Triglycerides are important secondarily — high triglycerides (above 200 mg/dL) reflect metabolic dysfunction and independently increase cardiovascular risk.
Yes — for many people, particularly those with moderately elevated LDL (130–159 mg/dL) without other cardiovascular risk factors, dietary changes can reduce LDL by 20–30 mg/dL. The most evidence-based dietary interventions: replacing saturated fat with unsaturated fat, adding 10–25g of soluble fiber daily (psyllium, oats, beans), consuming plant sterols/stanols (2g/day), and eating fatty fish 2–3× per week for triglycerides. If LDL remains above 160 mg/dL after 3–6 months of consistent dietary changes, medication is typically recommended.
Statins (atorvastatin, rosuvastatin, simvastatin) are the most prescribed class of medications in the world — they reduce LDL by 30–55% and have been shown to reduce major cardiovascular events (heart attacks, strokes) by 25–35% in high-risk patients. They work by blocking the liver enzyme (HMG-CoA reductase) that produces cholesterol. Common concerns: muscle aches affect 5–10% of users (true myopathy is rare); liver enzyme elevation is uncommon and usually mild; statins do not cause memory loss (the evidence consistently refutes this concern). If your physician has recommended a statin, the cardiovascular benefit for most patients significantly outweighs the risks.
For patients on cholesterol-lowering medications: test every 3 months to monitor treatment response — if home results indicate your LDL isn't reaching target, prompt your physician for a clinical test and possible medication adjustment. For people with borderline cholesterol making lifestyle changes: monthly home testing tracks progress and maintains motivation. For healthy adults monitoring their lipid health: quarterly to semi-annually is sufficient. Always alternate home tests with annual clinical venous blood draw tests for baseline accuracy calibration.
Every Tuesday we send you the single most useful review we published that week. No spam, no affiliate pitches, no clickbait — just the work.